Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy

202515 citationsJournal Article

Authors

Julio Rosenstock · Velocity Clinical Research (United States)

Timothy S. Bailey · Headlands Center for the Arts

Lisa Connery · Alliance for Multispecialty Research (United States)

Eden Miller

Cyrus Desouza · University of Nebraska at Omaha

Qianqian Wang · Eli Lilly (United States)

Jennifer Leohr · Eli Lilly (United States)

Abstract

In adults with type 2 diabetes who had not previously received insulin, once-weekly efsitora, administered in a fixed-dose regimen, was noninferior to once-daily glargine in reducing glycated hemoglobin levels. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT05662332.).

Topics & Keywords

Diabetes Treatment and Management Diabetes Management and Research Metabolism, Diabetes, and Cancer

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: New England Journal of Medicine

Volume 393, Issue 4, pp. 325-335

DOI: 10.1056/nejmoa2502796

Field-Weighted Citation Impact: 19.22